Found: 631
Select item for more details and to access through your institution.
Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 7, p. 828, doi. 10.1002/jcph.2421
- By:
- Publication type:
- Article
A population‐based time‐series analysis of opioid agonist treatment dispensed during pregnancy.
- Published in:
- Addiction, 2024, v. 119, n. 6, p. 1111, doi. 10.1111/add.16459
- By:
- Publication type:
- Article
Reducing the Likelihood of Opioid Overdose Fatalities on College and University Campuses: An Action Plan and Model.
- Published in:
- Journal of Community Health, 2024, v. 49, n. 3, p. 568, doi. 10.1007/s10900-023-01322-5
- By:
- Publication type:
- Article
Comment on Domzaridou et al.: Recognising the complexities of co‐prescriptions and lifestyle factors in opioid agonist treatment.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Nalmefene study: A faster alternative to naloxone.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2024, v. 26, n. 5, p. 1, doi. 10.1002/cpu30857
- By:
- Publication type:
- Article
Implementation and Evaluation of a Bystander Naloxone Training Course.
- Published in:
- Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health, 2024, v. 25, n. 3, p. 320, doi. 10.5811/westjem.60409
- By:
- Publication type:
- Article
Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 3, p. e243387, doi. 10.1001/jamanetworkopen.2024.3387
- By:
- Publication type:
- Article
Pregnancy- and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them.
- Published in:
- Women's Health (17455057), 2024, p. 1, doi. 10.1177/17455057231224181
- By:
- Publication type:
- Article
A Combination of a Dopamine Receptor 2 Agonist and a Kappa Opioid Receptor Antagonist Synergistically Reduces Weight in Diet-Induced Obese Rodents.
- Published in:
- Nutrients, 2024, v. 16, n. 3, p. 424, doi. 10.3390/nu16030424
- By:
- Publication type:
- Article
Medication Pipeline: Antidepressants and ADHD Rx.
- Published in:
- Psychiatric Times, 2024, v. 41, n. 2, p. 1
- By:
- Publication type:
- Article
Novel Therapeutic Navacaprant.
- Published in:
- Psychiatric Times, 2024, v. 41, n. 2, p. 27
- By:
- Publication type:
- Article
Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder.
- Published in:
- Addiction, 2024, v. 119, n. 1, p. 149, doi. 10.1111/add.16334
- By:
- Publication type:
- Article
Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder.
- Published in:
- Addiction, 2024, v. 119, n. 1, p. 158, doi. 10.1111/add.16374
- By:
- Publication type:
- Article
Orexin receptor agonist improves outcomes in narcolepsy, but with liver effects.
- Published in:
- Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 6, doi. 10.1002/pu.31112
- Publication type:
- Article
Opioid Abuse in the Elderly.
- Published in:
- Family Doctor: A Journal of the New York State Academy of Family Physicians, 2024, v. 12, n. 3, p. 26
- By:
- Publication type:
- Article
Kratom (Mitragyna speciosa): A Case Review of Use Before and During Pregnancy.
- Published in:
- Journal of Midwifery & Women's Health, 2024, v. 69, n. 1, p. 144, doi. 10.1111/jmwh.13558
- By:
- Publication type:
- Article
The safety and efficacy of methylnaltrexone in pediatric oncology patients: A single center experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 1, p. 4, doi. 10.1177/10781552231163540
- By:
- Publication type:
- Article
Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder.
- Published in:
- Maternal & Child Health Journal, 2023, v. 27, p. 104, doi. 10.1007/s10995-023-03672-x
- By:
- Publication type:
- Article
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 11, p. 9, doi. 10.1002/pu.31092
- Publication type:
- Article
Medications for Opioid Use Disorder During the Prenatal Period and Infant Outcomes.
- Published in:
- JAMA Pediatrics, 2023, v. 177, n. 11, p. 1228, doi. 10.1001/jamapediatrics.2023.3072
- By:
- Publication type:
- Article
Effects and Limitations of Naldemedine for Opioid-Induced Urinary Retention: A Case Report.
- Published in:
- Journal of Palliative Medicine, 2023, v. 26, n. 11, p. 1593, doi. 10.1089/jpm.2023.0269
- By:
- Publication type:
- Article
Response Rates to Methylnaltrexone in Hospitalized Cancer Patients.
- Published in:
- American Journal of Hospice & Palliative Medicine, 2023, v. 40, n. 10, p. 1093, doi. 10.1177/10499091221147903
- By:
- Publication type:
- Article
Gender and addiction and other mental disorders comorbidity: sociodemographic, clinical, and treatment differences.
- Published in:
- Archives of Women's Mental Health, 2023, v. 26, n. 5, p. 639, doi. 10.1007/s00737-023-01353-w
- By:
- Publication type:
- Article
Posterior reversible encephalopathy syndrome triggered by FLOT (5-fluorouracil, oxaliplatin, docetaxel, and calcium levofolinate) chemotherapy and thrombocytopenia (docetaxel and cisplatin) chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1503, doi. 10.1177/10781552231177597
- By:
- Publication type:
- Article
Education Intervention to Increase Naltrexone Use Among Adult Inpatients With Alcohol Use Disorder.
- Published in:
- Journal of Psychosocial Nursing & Mental Health Services, 2023, v. 61, n. 9, p. 10, doi. 10.3928/02793695-20230424-03
- By:
- Publication type:
- Article
Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 8, p. e2327739, doi. 10.1001/jamanetworkopen.2023.27739
- By:
- Publication type:
- Article
Screen for drug-induced gambling disorder in vulnerable patients receiving dopaminergic drugs.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 8, p. 297, doi. 10.1007/s40267-023-01015-y
- By:
- Publication type:
- Article
Naloxone Accessibility Under the State Standing Order Across Mississippi.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 7, p. e2321939, doi. 10.1001/jamanetworkopen.2023.21939
- By:
- Publication type:
- Article
Medications for treating alcohol use disorder: A narrative review.
- Published in:
- Alcohol: Clinical & Experimental Research, 2023, v. 47, n. 7, p. 1224, doi. 10.1111/acer.15118
- By:
- Publication type:
- Article
Naloxegol for Treatment of Opioid-Induced Constipation in the Pediatric Intensive Care Unit.
- Published in:
- Clinical Pediatrics, 2023, v. 62, n. 7, p. 721, doi. 10.1177/00099228221142129
- By:
- Publication type:
- Article
Postoperative pain assessment and management among nurses in selected hospitals in Benin City, Edo State, Nigeria.
- Published in:
- Journal of Integrative Nursing, 2023, v. 5, n. 3, p. 203, doi. 10.4103/jin.jin_54_23
- By:
- Publication type:
- Article
Impact of oral naloxegol vs subcutaneous methylnaltrexone in treatment of opioid-induced constipation in the hospital setting.
- Published in:
- American Journal of Health-System Pharmacy, 2023, v. 80, p. S70, doi. 10.1093/ajhp/zxac356
- By:
- Publication type:
- Article
Clarifying 'safer supply' to enrich policy discussions.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases.
- Published in:
- Biomedicines, 2023, v. 11, n. 6, p. 1620, doi. 10.3390/biomedicines11061620
- By:
- Publication type:
- Article
Sustained weight loss following switch from olanzapine to olanzapine/samidorphan (Lybalvi).
- Published in:
- Minerva Psychiatry, 2023, v. 64, n. 2, p. 269, doi. 10.23736/s2724-6612.23.02429-6
- By:
- Publication type:
- Article
Invited Commentary: On the Mathematization of Epidemiology as a Socially Engaged Quantitative Science.
- Published in:
- American Journal of Epidemiology, 2023, v. 192, n. 5, p. 757, doi. 10.1093/aje/kwad010
- By:
- Publication type:
- Article
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e237036, doi. 10.1001/jamanetworkopen.2023.7036
- By:
- Publication type:
- Article
Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments.
- Published in:
- Academic Emergency Medicine, 2023, v. 30, n. 4, p. 289, doi. 10.1111/acem.14683
- By:
- Publication type:
- Article
Efficacy and Safety of Naldemedine Administration for Opioid-Induced Constipation in Cancer Patients with Poor Performance Status.
- Published in:
- Journal of Palliative Medicine, 2023, v. 26, n. 4, p. 548, doi. 10.1089/jpm.2022.0495
- By:
- Publication type:
- Article
Barriers to Meeting Community Needs in New York State during COVID-19: Results From a Pilot Survey of Nongovernmental Population and Community Health Professionals.
- Published in:
- Health Promotion Practice, 2023, v. 24, n. 2, p. 332, doi. 10.1177/15248399211065412
- By:
- Publication type:
- Article
Project BETTER: A Family-Centered, Technology-Delivered Intervention for Pregnant People with Opioid Use Disorder.
- Published in:
- Children, 2023, v. 10, n. 2, p. 359, doi. 10.3390/children10020359
- By:
- Publication type:
- Article
Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness.
- Published in:
- Community Mental Health Journal, 2023, v. 59, n. 2, p. 345, doi. 10.1007/s10597-022-01012-x
- By:
- Publication type:
- Article
Design and in vitro characterization of in situ forming prolonged release implant formulations of a narcotic antagonist drug.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2023, v. 69, p. 119, doi. 10.33320/maced.pharm.bull.2023.69.03.058
- By:
- Publication type:
- Article
Patient Information Sheet.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2023, v. 25, n. 1, p. 9, doi. 10.1002/cpu.30743
- Publication type:
- Article
It's what the community demands: Results of community‐based emergency opioid overdose trainings.
- Published in:
- Public Health Nursing, 2023, v. 40, n. 1, p. 44, doi. 10.1111/phn.13151
- By:
- Publication type:
- Article
Drugs used for sedation in gastrointestinal endoscopy.
- Published in:
- Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi, 2022, v. 65, n. 11, p. 735, doi. 10.5124/jkma.2022.65.11.735
- By:
- Publication type:
- Article
Informing a collaborative-care model for delivering medication assisted treatment for opioid dependence (MATOD): An analysis of pharmacist, prescriber and patient perceptions.
- Published in:
- Pharmacy Research Review, 2022, n. 82, p. 3
- By:
- Publication type:
- Article
Rapid weight loss following switch from olanzapine to olanzapine/samidorphan (Lybalvi®).
- Published in:
- Minerva Psychiatry, 2022, v. 63, n. 3, p. 309, doi. 10.23736/S2724-6612.22.02361-2
- By:
- Publication type:
- Article
A peripheral opioid antagonist for treating urinary retention induced by opioids: A case report.
- Published in:
- Palliative Medicine, 2022, v. 36, n. 8, p. 1313, doi. 10.1177/02692163221107109
- By:
- Publication type:
- Article
Opioid-Induced Sexual Dysfunction in Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 4046, doi. 10.3390/cancers14164046
- By:
- Publication type:
- Article